logo
logo
Sign in

The Complete Blood Count Device Market Set For Rapid Growth Driven By Rising Prevalence Of Blood Disorders

avatar
Poonam
The Complete Blood Count Device Market Set For Rapid Growth Driven By Rising Prevalence Of Blood Disorders

Complete blood count (CBC) devices are medical devices used to count the number of red blood cells, white blood cells and platelets in a blood sample. CBC devices provide crucial information on complete blood cell count, hematocrit, hemoglobin and other important cell parameters. CBC tests are routinely used to diagnose anemia, infections, leukemia, and other disorders. Factors such as rising incidence of blood disorders, increasing adoption of point-of-care testing devices and technological advancements are driving the adoption of CBC devices globally. The Global Complete Blood Count Device Market is estimated to be valued at US$ 4922.18 Mn in 2024 and is expected to exhibit a CAGR of 12. % over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the Complete Blood Count Device market are Agilent Technologies, Inc., BD, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Danaher, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Shimadzu Corporation, Hitachi, Ltd., Bruker, Oxford Instruments, ZEISS International, Genome Medical, Inc., Hamilton Company, and Beckman Coulter, Inc. Growing demand for point-of-care diagnostic devices for quick and convenient test results is supporting market growth. Technological advancements focused on miniaturization, automation and artificial intelligence are enabling efficient and rapid analysis of CBC samples.

Market Trends

Rising adoption of automated hematology analyzers: Automated hematology analyzers provide accurate and reliable whole blood cell counts using advanced optics, flow cytometry, impedance technology and artificial intelligence. Their rising adoption is expected to drive the CBC device market.

Point-of-care testing devices gaining popularity: Portable and handheld point-of-care CBC testing devices enable timely diagnosis and treatment planning. Their increasing use in home care settings, ambulances, physician offices and emergency rooms is a major market trend.

Market Opportunities

Emerging economies in Asia Pacific and Latin America: These regions are expected to offer high growth opportunities for CBC device manufacturers driven by rising healthcare investments, growing medical needs and infectious disease burden.

Technological advancements in artificial intelligence: Application of artificial intelligence and machine learning techniques can help automate data analysis, quality control checks and issue alerts - opening new opportunities.

Impact of COVID-19 on Complete Blood Count Device Market Growth

The COVID-19 pandemic has greatly impacted the growth of the complete blood count device market. In the initial months of the outbreak in 2020, many non-essential medical procedures and routine checkups were postponed to prioritize the treatment of COVID-19 patients. This led to a decline in the demand and sales of complete blood count devices during that period.

However, as the pandemic spread worldwide, there was an increased need to monitor patients' complete blood counts to assess infectious risks, severity of infections, and recovery progress. Complete blood count tests help in identifying symptoms like leukocytosis, thrombocytopenia and anemia which are commonly associated with COVID-19. This elevated the importance of complete blood count devices in medical facilities for effective screening, diagnosis and management of the infected patients.

Going forward, to ensure preparedness for future outbreaks, healthcare systems are expected to invest more in automated hematology analyzers and point-of-care testing devices which can facilitate rapid complete blood count testing. Adoption of new technologies like artificial intelligence and Internet of Things can help generate more accurate and reliable test results. With continued research on COVID-19, complete blood count devices will remain critical for evaluating treatment responses and vaccine efficacy in clinical trials as well as post-vaccination surveillance programs.

North America Dominates Value Share in Complete Blood Count Device Market

North America represented the Complete Blood Count Device Market Demand   for complete blood count devices in terms of value in 2024 owing to well-established healthcare infrastructure, presence of leading market players, rising geriatric population susceptible to chronic diseases and increasing healthcare expenditure. The United States accounted for the major share in the regional market.

Asia Pacific Emerges as the Fastest Growing Region

Asia Pacific is poised to witness the fastest growth in the complete blood count device market during the forecast period of 2024 to 2030. This can be attributed to growing medical tourism industry, rising healthcare investments by governments especially in developing countries like India and China, expanding patient base of target diseases and improving access to diagnostic services in rural areas.

For more insights, read-https://www.pressreleasebulletin.com/complete-blood-count-device-market/

Check more trending articles related to this topic:https://techaxen.com/glycerol-the-versatile-elixir-fueling-industries-and-nurturing-skincare-unveiling-the-liquid-golds-hidden-potentials/

 


collect
0
avatar
Poonam
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more